The comprehensive treatment claim for COLD-fX® approved by Health Canada states that the product “helps reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.? Comprehensive therapeutic claims require support by the highest level of scientific evidence: randomized, double-blind, placebo-controlled clinical trials.
“This is our strongest point of medical recognition to date, and coming from the government authority whose responsibility it is to help Canadians maintain and improve their health, this approval should give great confidence to consumers,?said Dr. Jacqueline Shan, co-founder of CV Technologies, a University of Alberta spinoff company that developed COLD-fX.
Shan, who is also president, CEO and Chief Scientific Officer of CV Technologies added, “There are two novel therapeutic aspects to COLD-fX. First, COLD-fX is one of the very few medicines ?drugs or natural health products ?that Health Canada has approved for daily use as a preventative medicine. Second, COLD-fX can be taken to provide symptom relief for colds and flu."
Shan added that Health Canada reviewed all of CV Technologies published and unpublished data on COLD-fx before approving the claims.
The NHPD issues product licenses in several categories. Because COLD-fX® is a unique patented product, it was issued an NPN in the non-traditional category, which requires the highest level of scientific evidence. In contrast, claims with the term “tra
Source:University of Alberta